$RVP
Retractable Technologies Inc Stock $rvp

$rvp Overview Financials Valuation SEC Filings Company Website

2011 Q4 Form 10-K Financial Statement

#000110465913026195 Filed on April 01, 2013

Income Statement

Concept	2011 Q4	2010	2009 Q4
Revenue	$6.110M	$36.22M	$17.22M
YoY Change	-24.29%	-7.13%	142.19%
Cost Of Revenue	$5.020M	$23.70M	$10.21M
YoY Change	-28.59%	-7.06%	93.74%
Gross Profit	$1.090M	$12.52M	$7.010M
YoY Change	4.81%	-7.25%	280.98%
Gross Profit Margin	17.84%	34.57%	40.71%
Selling, General & Admin	$3.790M	$17.93M	$7.140M
YoY Change	21.09%	-22.7%	25.04%
% of Gross Profit	347.71%	143.23%	101.85%
Research & Development	$280.0K	$885.4K	$200.0K
YoY Change	55.56%	-11.46%	-23.08%
% of Gross Profit	25.69%	7.07%	2.85%
Depreciation & Amortization	$320.0K	$1.516M	$320.0K
YoY Change	-8.57%	8.3%	-8.57%
% of Gross Profit	29.36%	12.11%	4.56%
Operating Expenses	$4.060M	$19.19M	$7.340M
YoY Change	23.03%	-20.72%	22.74%
Operating Profit	-$2.970M	-$6.664M	-$330.0K
YoY Change	31.42%	-37.72%	-92.03%
Interest Expense	-$40.00K	$302.8K	-$20.00K
YoY Change	-20.0%		-108.7%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$3.020M	$2.225M	-$2.940M
YoY Change	371.88%	-116.73%	-24.81%
Income Tax	-$40.00K	-$176.1K	-$3.630M
% Of Pretax Income		-7.91%
Net Earnings	-$2.920M	$2.401M	$350.0K
YoY Change	156.14%	-122.23%	-108.24%
Net Earnings / Revenue	-47.79%	6.63%	2.03%
Basic Earnings Per Share		$0.04
Diluted Earnings Per Share	-$0.12	$0.04	$0.01
COMMON SHARES
Basic Shares Outstanding	25.28M shares	23.87M shares
Diluted Shares Outstanding		26.25M shares

Balance Sheet

Concept	2011 Q4	2010	2009 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$25.67M	$23.27M	$18.13M
YoY Change	10.31%	28.35%	-45.52%
Cash & Equivalents	$25.67M	$23.27M	$18.13M
Short-Term Investments
Other Short-Term Assets	$218.5K	$680.0K	$620.0K
YoY Change	-67.92%	9.68%	55.0%
Inventory	$6.237M	$8.680M	$6.910M
Prepaid Expenses
Receivables	$3.735M	$7.580M	$9.950M
Other Receivables	$40.00K	$10.00K	$3.650M
Total Short-Term Assets	$35.90M	$40.22M	$39.26M
YoY Change	-10.74%	2.45%	-9.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.65M	$12.56M	$14.23M
YoY Change	0.74%	-11.74%	-1.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$30.00K	$20.00K	$20.00K
YoY Change		0.0%	0.0%
Total Long-Term Assets	$13.02M	$12.97M	$14.68M
YoY Change	0.38%	-11.65%	-1.67%
TOTAL ASSETS
Total Short-Term Assets	$35.90M	$40.22M	$39.26M
Total Long-Term Assets	$13.02M	$12.97M	$14.68M
Total Assets	$48.92M	$53.19M	$53.94M
YoY Change	-8.03%	-1.39%	-7.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.659M	$3.850M	$7.000M
YoY Change	-4.92%	-45.0%	14.01%
Accrued Expenses	$950.0K	$1.910M	$2.150M
YoY Change	-50.26%	15.76%	-3.15%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$620.5K	$520.0K	$2.630M
YoY Change	19.41%	-80.23%	484.44%
Total Short-Term Liabilities	$6.125M	$9.990M	$13.20M
YoY Change	-38.66%	-24.32%	28.91%
LONG-TERM LIABILITIES
Long-Term Debt	$4.143M	$4.300M	$4.820M
YoY Change	-3.74%	-10.79%	-20.98%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$4.143M	$4.300M	$4.820M
YoY Change	-3.74%	-10.79%	-20.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.125M	$9.990M	$13.20M
Total Long-Term Liabilities	$4.143M	$4.300M	$4.820M
Total Liabilities	$10.27M	$14.29M	$18.02M
YoY Change	-28.14%	-20.7%	10.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.63M
YoY Change	-6.74%
Common Stock	$0.00
YoY Change
Preferred Stock	$57.28M
YoY Change	-0.68%
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$38.65M	$38.90M	$35.92M
YoY Change
Total Liabilities & Shareholders Equity	$48.92M	$53.19M	$53.94M
YoY Change	-8.03%	-1.39%	-7.86%

Cashflow Statement

Concept	2011 Q4	2010	2009 Q4
OPERATING ACTIVITIES
Net Income	-$2.920M	$2.401M	$350.0K
YoY Change	156.14%	-122.23%	-108.24%
Depreciation, Depletion And Amortization	$320.0K	$1.516M	$320.0K
YoY Change	-8.57%	8.3%	-8.57%
Cash From Operating Activities	$510.0K	$8.730M	$820.0K
YoY Change	-86.22%	-170.98%	-142.27%
INVESTING ACTIVITIES
Capital Expenditures	-$180.0K	$169.4K	-$80.00K
YoY Change	157.14%	-107.12%	-80.95%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change
Cash From Investing Activities	-$180.0K	-$170.0K	-$80.00K
YoY Change	157.14%	-92.86%	-80.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.590M	-3.420M	-120.0K
YoY Change	1666.67%	627.66%	-63.64%
NET CHANGE
Cash From Operating Activities	510.0K	8.730M	820.0K
Cash From Investing Activities	-180.0K	-170.0K	-80.00K
Cash From Financing Activities	-1.590M	-3.420M	-120.0K
Net Change In Cash	-1.260M	5.140M	620.0K
YoY Change	-135.59%	-133.93%	-123.05%
FREE CASH FLOW
Cash From Operating Activities	$510.0K	$8.730M	$820.0K
Capital Expenditures	-$180.0K	$169.4K	-$80.00K
Free Cash Flow	$690.0K	$8.561M	$900.0K
YoY Change	-81.7%	-186.3%	-159.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012	dei	Entity Central Index Key EntityCentralIndexKey	0000946563
CY2012	dei	Document Type DocumentType	10-K
CY2012	dei	Amendment Flag AmendmentFlag	false
CY2012	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2012	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2012	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2012	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
CY2012	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27248209	shares
CY2012	dei	Entity Registrant Name EntityRegistrantName	RETRACTABLE TECHNOLOGIES INC
CY2012	dei	Document Period End Date DocumentPeriodEndDate	2012-12-31
CY2012Q2	dei	Entity Public Float EntityPublicFloat	13279311	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25673263	USD
CY2011Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3734686	USD
CY2011Q4	us-gaap	Inventory Net InventoryNet	6237419	USD
CY2011Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	39485	USD
CY2011Q4	us-gaap	Other Assets Current OtherAssetsCurrent	218529	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	35903382	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12653856	USD
CY2010	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14260151	USD
CY2010	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	169415	USD
CY2010	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-169415	USD
CY2010	us-gaap	Proceeds From Repayments Of Long Term Debt And Capital Securities ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities	-2660336	USD
CY2010	us-gaap	Interest Paid InterestPaid	321610	USD
CY2011	us-gaap	Income Taxes Paid IncomeTaxesPaid	188754	USD
CY2011Q4	rvp	Intangible Assets And Other Assets Noncurrent IntangibleAssetsAndOtherAssetsNoncurrent	362976	USD
CY2011Q4	us-gaap	Assets Assets	48920214	USD
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3658576	USD
CY2011Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	620472	USD
CY2011Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	628794	USD
CY2011Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	122239	USD
CY2011Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1065943	USD
CY2011Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	29471	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6125495	USD
CY2011Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4143267	USD
CY2011Q4	us-gaap	Liabilities Liabilities	10268762	USD
CY2012Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	57613	USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	57284670	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19634770	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	38651452	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	48920214	USD
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	122202	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue		USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue		USD
CY2012Q4	us-gaap	Assets Assets	47632158	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	35441064	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8076952	USD
CY2012Q4	us-gaap	Liabilities Liabilities	11903162	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	35728996	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47632158	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2186190	USD
CY2011Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2078944	USD
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27252463	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25318700	shares
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2011	us-gaap	Sales Revenue Net SalesRevenueNet	32102296	USD
CY2010	us-gaap	Sales Revenue Net SalesRevenueNet	36219562	USD
CY2011	us-gaap	Cost Of Goods Sold CostOfGoodsSold	18556257	USD
CY2010	us-gaap	Cost Of Goods Sold CostOfGoodsSold	20757488	USD
CY2011	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	2643209	USD
CY2010	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	2940948	USD
CY2011	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21199466	USD
CY2010	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	23698436	USD
CY2011	us-gaap	Gross Profit GrossProfit	10902830	USD
CY2010	us-gaap	Gross Profit GrossProfit	12521126	USD
CY2011	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3439535	USD
CY2010	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3674168	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	815018	USD
CY2010	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	885445	USD
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10738110	USD
CY2010	us-gaap	Asset Impairment Charges AssetImpairmentCharges	365295	USD
CY2011	us-gaap	Operating Expenses OperatingExpenses	14992663	USD
CY2010	us-gaap	Operating Expenses OperatingExpenses	19185059	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-4089833	USD
CY2010	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23872783	shares
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26354786	shares
CY2010	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26248874	shares
CY2012	us-gaap	Operating Expenses OperatingExpenses	15115281	USD
CY2010	us-gaap	Operating Income Loss OperatingIncomeLoss	-6663933	USD
CY2011	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	62596	USD
CY2010	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	32324	USD
CY2011	us-gaap	Interest Expense InterestExpense	240484	USD
CY2010	us-gaap	Interest Expense InterestExpense	302843	USD
CY2011	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	5700000	USD
CY2010	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	9159089	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1432279	USD
CY2010	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2224637	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13797	USD
CY2010	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-176057	USD
CY2011	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	964047	USD
CY2010	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1370620	USD
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	454435	USD
CY2010	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1030074	USD
CY2011	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2010	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2011	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2010	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24171238	shares
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-3938863	USD
CY2012	us-gaap	Gross Profit GrossProfit	11176418	USD
CY2012	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	22468085	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4123074	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-4132892	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5051000	USD
CY2011	us-gaap	Accretion Expense AccretionExpense	17610	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1311746	USD
CY2010	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1516226	USD
CY2010	rvp	Gain Loss Related To Litigation Settlement Marketing Fees Payable GainLossRelatedToLitigationSettlementMarketingFeesPayable	1419760	USD
CY2010	us-gaap	Share Based Compensation ShareBasedCompensation	1340300	USD
CY2011	us-gaap	Inventory Write Down InventoryWriteDown	52835	USD
CY2010	rvp	Reserve For Non Contractual Deductions ReserveForNonContractualDeductions	850000	USD
CY2011	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1298044	USD
CY2010	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	133990	USD
CY2010	us-gaap	Accretion Expense AccretionExpense	30920	USD
CY2011	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2391937	USD
CY2010	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1774822	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1305379	USD
CY2010	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2650567	USD
CY2011	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	27454	USD
CY2010	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-3643606	USD
CY2011	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-462715	USD
CY2010	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	56851	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1054563	USD
CY2010	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4417753	USD
CY2011	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-3646555	USD
CY2010	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	3313260	USD
CY2011	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-125529	USD
CY2010	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	155000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	5513773	USD
CY2010	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	8730672	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	826091	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-826091	USD
CY2011	us-gaap	Proceeds From Repayments Of Long Term Debt And Capital Securities ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities	-612927	USD
CY2011	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	1357275	USD
CY2011	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	54369	USD
CY2010	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	115600	USD
CY2011	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	364625	USD
CY2010	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	876566	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-2280458	USD
CY2010	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-3421302	USD
CY2011	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	2407224	USD
CY2010	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	5139955	USD
CY2011	us-gaap	Interest Paid InterestPaid	279691	USD
CY2010	us-gaap	Income Taxes Paid IncomeTaxesPaid	16000	USD
CY2011	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	534986	USD
CY2012	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	57613	USD
CY2012	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	290050	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	641830	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-510117	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	158337	USD
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	122202	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23266039	USD
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18126084	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25963313	USD
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	35920473	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1335858	USD
CY2010	us-gaap	Net Income Loss NetIncomeLoss	2400694	USD
CY2010	us-gaap	Dividends Preferred Stock DividendsPreferredStock	876566	USD
CY2010	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	115600	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1340300	USD
CY2012	us-gaap	Accretion Expense AccretionExpense	3773	USD
CY2012	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2012	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	38900501	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	1418482	USD
CY2011	us-gaap	Dividends Preferred Stock DividendsPreferredStock	364625	USD
CY2011	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	54369	USD
CY2011	rvp	Purchase Of Preferred Stock PurchaseOfPreferredStock	1357275	USD
CY2012	us-gaap	Inventory Write Down InventoryWriteDown	120000	USD
CY2012	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	107246	USD
CY2012	us-gaap	Use Of Estimates UseOfEstimates	<div style='font-size:10.0pt;FONT-FAMILY: Times New Roman;'> <p style="MARGIN: 0in 0in 0pt 27pt; TEXT-ALIGN: justify"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Accounting estimates</font></b></p> <p style="MARGIN: 0in 0in 0pt 27pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt 27pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ significantly from those estimates.</font></p> <p style="MARGIN: 0in 0in 0pt 27pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></div>
CY2010	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2376091	shares
CY2011	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	81723	shares
CY2012	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style='font-size:10.0pt;FONT-FAMILY: Times New Roman;'> <p style="MARGIN: 0in 0in 0pt 27pt; TEXT-ALIGN: justify"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Reclassifications</font></b></p> <p style="MARGIN: 0in 0in 0pt 27pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt 27pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Contractual pricing allowances are presented in Accounts payable at December 31, 2012. Such allowances were netted against distributors’ individual balances and the resulting net balances were reflected in Accounts receivable or Accounts payable, as appropriate, in prior years. Accounts receivable and Accounts payable at December 31, 2011 have each increased $158,275 to conform with the current year’s presentation. This reclassification had no effect on stockholders’ equity or results of operations.</font></p> <p style="MARGIN: 0in 0in 0pt 27pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></div>
CY2012	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style='font-size:10.0pt;FONT-FAMILY: Times New Roman;'> <p style="MARGIN: 0in 0in 0pt 27pt; TEXT-ALIGN: justify"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Concentration risks</font></b></p> <p style="MARGIN: 0in 0in 0pt 27pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt 27pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The Company’s financial instruments exposed to concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable.  Cash balances, some of which exceed federally insured limits, are maintained in financial institutions; however, Management believes the institutions are of high credit quality.  The majority of accounts receivable are due from companies which are well-established entities.  As a consequence, Management considers any exposure from concentrations of credit risks to be limited.</font></p> <p style="MARGIN: 0in 0in 0pt 27pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt 27.35pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The following table reflects our significant customers in 2012, 2011, and 2010:</font></p> <p style="MARGIN: 0in 0in 0pt 24.5pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <table style="MARGIN-LEFT: 27.35pt; WIDTH: 89.88%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="89%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 33.8%; PADDING-TOP: 0in" valign="bottom" width="33%"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.78%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 62.32%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="62%" colspan="5"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Years Ended December 31,</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.12%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 33.8%; PADDING-TOP: 0in" valign="bottom" width="33%"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.78%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 18.92%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="18%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">2012</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.78%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 18.92%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="18%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">2011</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.78%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 18.92%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="18%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">2010</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.12%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 33.8%; PADDING-TOP: 0in" valign="top" width="33%"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Number of significant customers</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.78%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 18.92%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="18%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">3</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.78%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 18.92%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="18%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">4</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.78%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 18.92%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="18%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">3</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.12%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 33.8%; PADDING-TOP: 0in" valign="top" width="33%"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Aggregate dollar amount of net sales to significant customers</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.78%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 18.92%; PADDING-TOP: 0in" valign="bottom" width="18%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$13.7 million</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.78%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 18.92%; PADDING-TOP: 0in" valign="bottom" width="18%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$16.2 million</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.78%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 18.92%; PADDING-TOP: 0in" valign="bottom" width="18%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$13.9 million</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.12%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 33.8%; PADDING-TOP: 0in" valign="top" width="33%"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Percentage of net sales to significant customers</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.78%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 18.92%; PADDING-TOP: 0in" valign="bottom" width="18%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">40.6%</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.78%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 18.92%; PADDING-TOP: 0in" valign="bottom" width="18%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">50.6%</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.78%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 18.92%; PADDING-TOP: 0in" valign="bottom" width="18%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">38.6%</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.12%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt 24.5pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt 27pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Considering the current economic climate, the Company increased its allowance for doubtful accounts by approximately $107 thousand this year.</font></p> <p style="MARGIN: 0in 0in 0pt 27pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt 27pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The Company manufactures syringes in Little Elm, Texas as well as utilizing manufacturers in China.  The Company purchases most of its product components from single suppliers, including needle adhesives and packaging materials.  There are multiple sources of these materials.  The Company obtained roughly 72.0% of its finished products in 2012 through Double Dove, a Chinese manufacturer.  The Company obtained approximately 67.1% and 64.1% of its finished products from Double Dove in 2011 and 2010, respectively.  In the event that the Company becomes unable to purchase such product from Double Dove, the Company would need to find an alternate supplier for its 0.5mL insulin syringe, its 2mL, 5mL, and 10mL syringes, and its autodisable syringe and increase domestic production for 1mL and 3mL syringes.</font></p> <p style="MARGIN: 0in 0in 0pt 27pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></div>
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26219728	shares
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	220268	USD
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	49626	USD
CY2012Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	239752	USD
CY2011Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	258435	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1127166	USD
CY2012	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	36596	USD
CY2011	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	57000	USD
CY2010	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	50000	USD
CY2012	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P17Y
CY2012	rvp	Number Of Significant Customers NumberOfSignificantCustomers	3	item
CY2011	rvp	Number Of Significant Customers NumberOfSignificantCustomers	4	item
CY2010	rvp	Number Of Significant Customers NumberOfSignificantCustomers	3	item
CY2012	rvp	Revenue Recognition Period For Return Of Incorrect Shipments RevenueRecognitionPeriodForReturnOfIncorrectShipments	P10D
CY2012	rvp	Revenue Recognition Overstock Return Limit Number RevenueRecognitionOverstockReturnLimitNumber	2	item
CY2012	rvp	Revenue Recognition Overstock Return Period RevenueRecognitionOverstockReturnPeriod	P12M
CY2012	rvp	Revenue Recognition Maximum Percentage Of Distributors Total Purchase In Prior Twelve Month Period For Overstock Return RevenueRecognitionMaximumPercentageOfDistributorsTotalPurchaseInPriorTwelveMonthPeriodForOverstockReturn	0.01	pure
CY2012	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	918108	USD
CY2011	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-10120	USD
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26219728	shares
CY2011	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2101825	shares
CY2012Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1692133	USD
CY2011Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1282357	USD
CY2012Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3537872	USD
CY2011Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5213497	USD
CY2012Q4	us-gaap	Inventory Gross InventoryGross	5230005	USD
CY2011Q4	us-gaap	Inventory Gross InventoryGross	6495854	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18984018	USD
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17719693	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	4990253	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11899650	USD
CY2012	us-gaap	Depreciation Depreciation	1264326	USD
CY2011	us-gaap	Depreciation Depreciation	1267813	USD
CY2010	us-gaap	Depreciation Depreciation	1482591	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	30883668	USD
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	30373549	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1008743	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	494399	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	678614	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	207879	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	330129	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	286520	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	71532	USD
CY2011	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	43934	USD
CY2010	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	43440	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	14559	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	14559	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	14559	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	14559	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	14559	USD
CY2012Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	1400740	USD
CY2011Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	869334	USD
CY2012Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	162969	USD
CY2011Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	134790	USD
CY2012Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	101961	USD
CY2011Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1118679	USD
CY2011Q4	rvp	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Related To Employee DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRelatedToEmployee	682810	USD
CY2011Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	397449	USD
CY2011Q4	rvp	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Related To Non Employee DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRelatedToNonEmployee	79939	USD
CY2011Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5651871	USD
CY2011Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	61819	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1665670	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	315086	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	247064	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	149744	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	159182	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	169211	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	3101009	USD
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	60401	USD
CY2011Q4	us-gaap	Long Term Debt LongTermDebt	4763739	USD
CY2012Q4	us-gaap	Long Term Debt LongTermDebt	4141296	USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	315086	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3826210	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	61607	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	62812	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	59966	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	184385	USD
CY2011Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	768455	USD
CY2011Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	768455	USD
CY2011Q4	rvp	Deferred Tax Assets Liabilities Net Before Valuation DeferredTaxAssetsLiabilitiesNetBeforeValuation	4883416	USD
CY2011Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4883416	USD
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1785	USD
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	8033	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	9818	USD
CY2011	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-29070	USD
CY2010	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-204507	USD
CY2011	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	42867	USD
CY2010	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	28450	USD
CY2011	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	13797	USD
CY2010	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-176057	USD
CY2012	rvp	Income Tax Expense Benefit Attributable To Carryback Lossess IncomeTaxExpenseBenefitAttributableToCarrybackLossess	12850183	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4873433	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1165658	USD
CY2012Q4	rvp	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Related To Employee DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRelatedToEmployee	295696	USD
CY2012Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	319830	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6670163	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	631109	USD
CY2012Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	631109	USD
CY2012Q4	rvp	Deferred Tax Assets Liabilities Net Before Valuation DeferredTaxAssetsLiabilitiesNetBeforeValuation	6039054	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6039054	USD
CY2011Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3372994	USD
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.029	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.029	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.029	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.280	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.012	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.020	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.091	pure
CY2012	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	122202	USD
CY2011	rvp	Effective Income Tax Rate Reconciliation Return To Accrual Adjustments EffectiveIncomeTaxRateReconciliationReturnToAccrualAdjustments	-0.028	pure
CY2010	rvp	Effective Income Tax Rate Reconciliation Return To Accrual Adjustments EffectiveIncomeTaxRateReconciliationReturnToAccrualAdjustments	-0.150	pure
CY2011	rvp	Effective Income Tax Rate Reconciliation Alternative Minimum Tax EffectiveIncomeTaxRateReconciliationAlternativeMinimumTax	0.034	pure
CY2010	rvp	Effective Income Tax Rate Reconciliation Alternative Minimum Tax EffectiveIncomeTaxRateReconciliationAlternativeMinimumTax	0.058	pure
CY2011	rvp	Effective Income Tax Rate Reconciliation Release Of Valuation Allowance Net Operating Loss Carryforward EffectiveIncomeTaxRateReconciliationReleaseOfValuationAllowanceNetOperatingLossCarryforward	0.390	pure
CY2010	rvp	Effective Income Tax Rate Reconciliation Release Of Valuation Allowance Net Operating Loss Carryforward EffectiveIncomeTaxRateReconciliationReleaseOfValuationAllowanceNetOperatingLossCarryforward	0.452	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.003	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.005	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.005	pure
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002	pure
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.010	pure
CY2010	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.079	pure
CY2012	rvp	Preferred Stock Number Of Shares Exchanged Against Common Stock And Cash PreferredStockNumberOfSharesExchangedAgainstCommonStockAndCash	1277464	shares
CY2012	rvp	Stock Issued During Period Shares Exchanges StockIssuedDuringPeriodSharesExchanges	1277464	shares
CY2012	rvp	Accrued Dividends Eliminated AccruedDividendsEliminated	3592659	USD
CY2012	rvp	Amount Of Annual Dividend Reduction AmountOfAnnualDividendReduction	450758	USD
CY2012	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	67102	shares
CY2012Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2000000	shares
CY2012Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.81
CY2012Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1620000	USD
CY2012	us-gaap	Defined Contribution Plan Maximum Annual Contribution Per Employee Percent DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent	0.88	pure
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1441308	USD
CY2012	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	787393	USD
CY2012	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-29471	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	510117	USD
CY2012	us-gaap	Sales Revenue Net SalesRevenueNet	33644503	USD
CY2012Q4	us-gaap	Entity Wide Disclosure On Geographic Areas Long Lived Assets In Entitys Country Of Domicile EntityWideDisclosureOnGeographicAreasLongLivedAssetsInEntitysCountryOfDomicile	11679592	USD
CY2011Q4	us-gaap	Entity Wide Disclosure On Geographic Areas Long Lived Assets In Entitys Country Of Domicile EntityWideDisclosureOnGeographicAreasLongLivedAssetsInEntitysCountryOfDomicile	12412502	USD
CY2010Q4	us-gaap	Entity Wide Disclosure On Geographic Areas Long Lived Assets In Entitys Country Of Domicile EntityWideDisclosureOnGeographicAreasLongLivedAssetsInEntitysCountryOfDomicile	12297942	USD
CY2012Q4	us-gaap	Entity Wide Disclosure On Geographic Areas Long Lived Assets In Foreign Countries EntityWideDisclosureOnGeographicAreasLongLivedAssetsInForeignCountries	220058	USD
CY2011Q4	us-gaap	Entity Wide Disclosure On Geographic Areas Long Lived Assets In Foreign Countries EntityWideDisclosureOnGeographicAreasLongLivedAssetsInForeignCountries	241354	USD
CY2010Q4	us-gaap	Entity Wide Disclosure On Geographic Areas Long Lived Assets In Foreign Countries EntityWideDisclosureOnGeographicAreasLongLivedAssetsInForeignCountries	262650	USD
CY2012	rvp	Preferred Stock Number Of Classes Outstanding PreferredStockNumberOfClassesOutstanding	1	item
CY2010	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1340300	USD
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	124221	USD
CY2012Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	157215	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9818	USD
CY2012	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	230450	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3694307	USD
CY2012Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	9431	USD
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	783760	USD
CY2012Q4	rvp	Intangible Assets And Other Assets Noncurrent IntangibleAssetsAndOtherAssetsNoncurrent	291444	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5099884	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	809592	USD
CY2012Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	129107	USD
CY2012Q4	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	58617308	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23767662	USD
CY2012	us-gaap	Cost Of Goods Sold CostOfGoodsSold	19776198	USD
CY2012	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	2691887	USD
CY2012	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4220809	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	871851	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10022621	USD
CY2012	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	46999	USD
CY2012	us-gaap	Interest Expense InterestExpense	231210	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	66867	USD
CY2012	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-30054	USD
CY2012	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	565231	USD
CY2012	us-gaap	Proceeds From Repayments Of Long Term Debt And Capital Securities ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities	-626219	USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1620701	USD
CY2012	us-gaap	Interest Paid InterestPaid	264033	USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid	3474	USD
CY2012	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1155638	USD
CY2011	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-559266	USD
CY2012Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00
CY2011Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00
CY2012Q4	us-gaap	Property Plant And Equipment Fair Value Disclosure PropertyPlantAndEquipmentFairValueDisclosure	0	USD
CY2012	rvp	Number Of Products Consigned To Customers NumberOfProductsConsignedToCustomers	0	item
CY2012Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	USD
CY2012	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	1357275	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	USD
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1620701	USD
CY2012	us-gaap	Dividends Preferred Stock DividendsPreferredStock	230450	USD

Files In Submission

Name	View Source	Status
0001104659-13-026195-index-headers.html	Edgar Link	pending
0001104659-13-026195-index.html	Edgar Link	pending
0001104659-13-026195.txt	Edgar Link	pending
0001104659-13-026195-xbrl.zip	Edgar Link	pending
a13-1359_110k.htm	Edgar Link	pending
a13-1359_1ex23.htm	Edgar Link	pending
a13-1359_1ex31d1.htm	Edgar Link	pending
a13-1359_1ex31d2.htm	Edgar Link	pending
a13-1359_1ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
g13591ba01i001.gif	Edgar Link	pending
g13591ba05i001.gif	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rvp-20121231.xml	Edgar Link	completed
rvp-20121231.xsd	Edgar Link	pending
rvp-20121231_cal.xml	Edgar Link	unprocessable
rvp-20121231_def.xml	Edgar Link	unprocessable
rvp-20121231_lab.xml	Edgar Link	unprocessable
rvp-20121231_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RVP
Retractable Technologies Inc Stock $rvp

2011 Q4 Form 10-K Financial Statement

#000110465913026195 Filed on April 01, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RVP Retractable Technologies Inc Stock $rvp

2011 Q4 Form 10-K Financial Statement

#000110465913026195 Filed on April 01, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RVP
Retractable Technologies Inc Stock $rvp